Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOS2 | P35228 | 9/20 | 0.46 |
| ▸ | NOS3 | P29474 | 5/20 | 0.46 |
| ▸ | NOS1 | P29475 | 5/20 | 0.46 |
| ▸ | ACACB | O00763 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | PPARG | P37231 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | MDM4 | O15151 | 1/20 | 0.40 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.40 |
| ▸ | ATM | Q13315 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29820660 | 0.84 | NOS2 (0.49) | NOS2NOS3NOS1ACACBMEN1 | |
| SCHEMBL28912122 | 0.83 | NOS2 (0.58) | NOS2NOS3NOS1ALDH1A1LMNA | |
| SCHEMBL28912123 | 0.83 | NOS2 (0.58) | NOS2NOS3NOS1ALDH1A1LMNA | |
| SCHEMBL8815510 | 0.80 | ACACB (0.45) | ACACBALDH1A1PPARG | |
| SCHEMBL13252035 | 0.79 | ABCB1 (0.57) | ACACBMEN1ALDH1A1LMNAKMT2A | |
| SCHEMBL13933239 | 0.79 | ABCB1 (0.57) | ACACBMEN1ALDH1A1LMNAKMT2A | |
| SCHEMBL3431290 | 0.78 | ABCB1 (0.52) | ACACBPPARG | |
| SCHEMBL29821020 | 0.77 | ACACB (0.49) | NOS2NOS3NOS1ACACBMEN1 | |
| SCHEMBL13919532 | 0.74 | CTSL (0.63) | MEN1ALDH1A1LMNAKMT2ATSHR | |
| SCHEMBL3359560 | 0.74 | CTSL (0.63) | MEN1ALDH1A1LMNAKMT2ATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240309557-A1 | PYRAZOLE AND PYRAZOLINE-CONTAINING PEPTIDES, HIGH THROUGHPUT CLICK LIBRARIES, AND METHODS | UNM RAINFOREST INNOVATIONS (US) | 2024-09-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240309557-A1 | PYRAZOLE AND PYRAZOLINE-CONTAINING PEPTIDES, HIGH THROUGHPUT CLICK LIBRARIES, AND METHODS | PTMS, VIP, DNPEP | NOS2 2462/4885NOS3 905/4885NOS1 2028/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.